Contract facts
FederalNo full NAICS 334516 intel page yet. Browse NAICS intelligence
Immunostainer for Washington DC Vamc is a federal award for 245-Network Contract Office 5 (36C245) held by Roche Diagnostics Corp. Estimated value $110K ($110K obligated). Current period of performance ends Sep 2, 2022. Last award drew 2 bidders. Place of performance: INDIANAPOLIS IN.
Immunostainer for washington dc vamc. Latest action is a modification.
Recompete timing
PublicCurrent PoP ended Sep 2, 2022 (1510 days ago). The usual 12–18 month agency planning window is closed — recompete action looks late / overdue relative to a normal cycle. Watch for bridge orders, follow-ons, or a new solicitation.
Want the durability read on 36C24522F0310? One Pursuit Analysis, $500, inside 48 business hours.
- 48 business hours
- $500
- Credits toward the Pack
Incumbent footprint
Public recordRoche Diagnostics Corp — $245.9M obligated across 1,391 awards (firm-wide, all agencies) · lead buyer Department of Veterans Affairs (VA).
Related awards
Same parent · incumbentQuery this award live in SCOUT via MCP — personalized scoring, watchlists, and capture workflow across the corpus. Learn about SCOUT MCP →
Frequently asked questions
What is contract 36C24522F0310?
36C24522F0310 (Immunostainer for washington DC vamc) is a 245-Network Contract Office 5 (36C245) award with a potential value of $110K, currently held by Roche Diagnostics Corp. Figures are USASpending-sourced public-record facts plus SCOUT recompete analysis.
What is 36C245-22-F-0310?
36C245-22-F-0310 is the dashed form of PIID 36C24522F0310 (Immunostainer for washington DC vamc), held by Roche Diagnostics Corp. Same award — SCOUT canonicalizes compact, dashed, and parent-child identifiers to one brief.
Which office awarded 36C24522F0310?
245-Network Contract Office 5 (36C245) awarded 36C24522F0310 to Roche Diagnostics Corp (potential $110K).
Who is the incumbent on 36C24522F0310?
Roche Diagnostics Corp is the incumbent with $245.9M across 1391 related awards in SCOUT’s public footprint. The current period of performance ends Sep 2, 2022.
When does Roche Diagnostics Corp’s 36C24522F0310 come up for recompete?
SCOUT tracks a period-of-performance end of Sep 2, 2022. Actual solicitation timing can shift with extensions, bridges, or consolidations.
Want the durability read on 36C24522F0310? One Pursuit Analysis, $500, inside 48 business hours.
One Pursuit Analysis is $500 and credits toward the Sprint Pack. Delivery is 48 business hours. Start with the free Exposure Check if you want the list first.
No card · under a minute · then the Sprint menu
Use SCOUT in your AI client — $29/moClassify + search inside Claude, ChatGPT, Cursor
Compare plansData: Showing contracts ≥ $100K from federal procurement records (FPDS-NG, SAM.gov, and related repositories), normalized by PrimeRFP SCOUT. Each row keyed by Award ID (PIID); task orders appear as independent rows.